AZN (AZN) Stock Price & Analysis
AZN (AZN) fell 1.26% to USD 162.7 as of September 8, 2026 at 03:32 UTC, according to Nexqual real-time market data.
AZN last closed at USD 162.7; the session ranged USD 161.13–163.78 on volume of 3,069,984 shares. Market capitalization is —, with a 52-week range of USD 145.8–212.71 (NYQ). Source: Nexqual, September 8, 2026 at 03:32 UTC.
Key Statistics (as of September 8, 2026 at 03:32 UTC)
| Price | USD 162.7 |
|---|---|
| Change | ▼ 1.26% (down) |
| Previous Close | USD 162.7 |
| Open | USD 162.7 |
| Day Range | USD 161.13 – 163.78 |
| 52-Week Range | USD 145.8 – 212.71 |
| Volume | 3,069,984 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (AZN)
Nexqual's technical model rates AZN "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 03:32 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.39 (neutral) |
| vs SMA50 | Below (USD 169.1) |
| MACD | -1.06 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GSK | GSK plc | USD 49.89 | ▼ 1.09% |
| NVS | Novartis AG | USD 159.99 | ▼ 1.52% |
| SNY | Sanofi | USD 44.24 | ▼ 0.52% |
| MRNA | Moderna, Inc. | USD 145.55 | ▼ 3.49% |
| BNTX | BioNTech SE | USD 103.76 | ▼ 0.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:32 UTC. This page is informational and not investment advice.